Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Sep 3, 2014

Why Is Everybody Picking on Sovaldi?

It is highly cost-effective at the $84,000 price, but....

Why Is Everybody Picking on Sovaldi?

A reduction in price for the HCV drug could open up the potential market and increase dollar sales above those anticipated for the present price. [© ZIQUIU - Fotolia.com]

  • For those infected with hepatitis C virus (HCV), the new drug Sovaldi seems like a godsend. As one part of a triple-drug therapy, it ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »